Učitavanje...
Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
Ulipristal acetate (UPA) was introduced as a novel progesterone receptor modulator as effective therapy for symptomatic fibroids. Randomised clinical trials established its effectiveness in the management of heavy menstrual bleeding due to uterine leiomyomas. The trials did not find any significant...
Spremljeno u:
| Izdano u: | Adv Ther |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Healthcare
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7854411/ https://ncbi.nlm.nih.gov/pubmed/33201387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01555-z |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|